Skip to content
Redbiotec AG Logo Redbiotec AG Logo Redbiotec AG Logo
  • Home
  • Company
    • Leadership/ Board
    • Scientific Advisory Board
    • Partners
    • Careers (1 open)
  • Products
    • COMOS – cancer therapies (RONC1-2)
    • BRISPR – cancer therapies (RONC3)
    • HSV2 therapeutic vaccine program
  • Technology
  • News
    • News
    • In the press
  • Contact
  • Home
  • Company
    • Leadership/ Board
    • Scientific Advisory Board
    • Partners
    • Careers (1 open)
  • Products
    • COMOS – cancer therapies (RONC1-2)
    • BRISPR – cancer therapies (RONC3)
    • HSV2 therapeutic vaccine program
  • Technology
  • News
    • News
    • In the press
  • Contact
Previous Next

Article “Handelszeitung”

Article about Redbiotec in “Handelszeitung”. Read here.

Christian Schaub2018-07-20T15:51:05+00:00September 13th, 2017|In the press|
  • Company
    • Leadership/ Board
    • Scientific Advisory Board
    • Partners
    • Careers (1 open)
  • Products
    • COMOS – cancer therapies (RONC1-2)
    • BRISPR – cancer therapies (RONC3)
    • HSV2 therapeutic vaccine program
  • Technology
  • News
    • News
    • In the press
Redbiotec AG
Wagistrasse 23
8952 Schlieren
Switzerland
Tel.: +41 44 738 20 00
Fax: +41 44 738 20 01
contact@redbiotec.ch


© Redbiotec AG | 2006 - 2018 | Disclaimer | Contact
TwitterLinkedIn